Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Quentin30 is a pathological prevaricator.

<< Previous

Bullboard Posts

Next >>

Comment by Azzak34on Oct 24, 2023 4:54pm

120 Views

Post# 35699026

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Quentin30 is a pathological prevaricator.

Yes Norm, git-em.

Wasting your time bashing a stock you're either not in or actually are and don't believe in are both equally inane practices. This board should be to share thoughts and ideas about the science, biotech environment.... even to speculate, not to complain all day. Pack of whiny betches.

I'll be holding until the end, I imagine you other fannies will too. You just need a little poosy pow-wow to make yourself feel better.

<< Previous

Bullboard Posts

Next >>

The top 10 artificial intelligence penny stocks